×

15 April 2024
17:00 BST | 18:00 CEST | 12:00 EDT

This exclusive event will delve into optimal dosing strategies, overcoming barriers to guideline-directed therapy, and real-world applications through a compelling case study and panel discussion.

Register now! 

Overview

Join cardiologists Dr. Shelley Zieroth (University of Manitoba, Winnipeg, CA) and Dr. Aaron Wong (Princess of Wales Hospital, Wales, UK) and nephrologists Dr. Andrew Frankel (Imperial College Healthcare NHS Trust, London, UK), and Dr. Manish Sood (University of Ottawa, CA) when they discuss the nuanced landscape of RAASi management in cardiorenal patients in this live roundtable.

In this discussion, our expert faculty consider approaches to optimal RAASi dosing and strategies to improve patient outcomes. The programme integrates data-driven insights, established guidelines, and expert consensus, offering participants a holistic understanding of RAASi management.

A case study will highlight how to overcome barriers to optimal guideline-directed medical therapy and panel discussion will bridge theory and real-world application, providing you with actionable tools to implement optimal practices in your daily clinical pursuits.

Register today to secure your place! 

In collaboration with Radcliffe Group (Radcliffe Cardiology and Radcliffe Medical Education).

Radcliffe equips healthcare professionals with the skills and practical insights they need to do their best for patients, by bringing the world’s cardiovascular knowledge to life. Radcliffe combines scientific rigor with communications expertise and technical mastery, to make knowledge-sharing as effortless and effective as possible.

Radcliffe Medical Education (RME) is a specialist provider of Continuing Medical Education (CME) and Independent Medical Education (IME) in the Cardiovascular, Renal and Metabolic (CVRM) space.

RME is uniquely positioned in being able to provide insight from a truly global network of CVRM opinion leaders, together with the same digital capabilities that have become a defining quality of Radcliffe Cardiology.

This programme is supported by an unrestricted educational grant from AstraZeneca.


Resources